241 related articles for article (PubMed ID: 20889205)
1. Targeting of polymeric nanoparticles to lung metastases by surface-attachment of YIGSR peptide from laminin.
Sarfati G; Dvir T; Elkabets M; Apte RN; Cohen S
Biomaterials; 2011 Jan; 32(1):152-61. PubMed ID: 20889205
[TBL] [Abstract][Full Text] [Related]
2. Polymeric nanospheres modified with YIGSR peptide for tumor targeting.
Dubey PK; Singodia D; Vyas SP
Drug Deliv; 2010; 17(7):541-51. PubMed ID: 20560774
[TBL] [Abstract][Full Text] [Related]
3. Liposomes modified with YIGSR peptide for tumor targeting.
Dubey PK; Singodia D; Vyas SP
J Drug Target; 2010 Jun; 18(5):373-80. PubMed ID: 20020817
[TBL] [Abstract][Full Text] [Related]
4. Laminin receptor-targeted etoposide loaded polymeric micelles: a novel approach for the effective treatment of tumor metastasis.
Ukawala M; Chaudhari K; Rajyaguru T; Manjappa AS; Murthy RS; Gude R
J Drug Target; 2012 Jan; 20(1):55-66. PubMed ID: 21967151
[TBL] [Abstract][Full Text] [Related]
5. Bioconjugation of laminin-related peptide YIGSR with polyvinyl pyrrolidone increases its antimetastatic effect due to a longer plasma half-life.
Mu Y; Kamada H; Kodaira H; Sato K; Tsutsumi Y; Maeda M; Kawasaki K; Nomizu M; Yamada Y; Mayumi T
Biochem Biophys Res Commun; 1999 Nov; 264(3):763-7. PubMed ID: 10544005
[TBL] [Abstract][Full Text] [Related]
6. Synthetic cell-adhesive laminin peptide YIGSR conjugated with polyethylene glycol has improved antimetastatic activity due to a longer half-life in blood.
Kaneda Y; Yamamoto S; Kihira T; Tsutsumi Y; Nakagawa S; Miyake M; Kawasaki K; Mayumi T
Invasion Metastasis; 1995; 15(3-4):156-62. PubMed ID: 8621271
[TBL] [Abstract][Full Text] [Related]
7. Effect of Matrigel and laminin peptide YIGSR on tumor growth and metastasis.
Yamamura K; Kibbey MC; Jun SH; Kleinman HK
Semin Cancer Biol; 1993 Aug; 4(4):259-65. PubMed ID: 8400148
[TBL] [Abstract][Full Text] [Related]
8. Pentapeptide YIGSR-mediated HT-1080 fibrosarcoma cells targeting of adriamycin encapsulated in sterically stabilized liposomes.
Lopez-Barcons LA; Polo D; Reig F; Fabra A
J Biomed Mater Res A; 2004 Apr; 69(1):155-63. PubMed ID: 14999763
[TBL] [Abstract][Full Text] [Related]
9. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.
Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q
Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635
[TBL] [Abstract][Full Text] [Related]
10. In vivo binding of the radioiodinated peptide YIGSR on B16 melanoma cells.
Kouzi-Koliakos K; Koliakos G; Trontzos C; Papageorgiou A; Iliadis S; Triantos A; Dimitriadou A; Kanellaki M
Invasion Metastasis; 1996; 16(6):322-9. PubMed ID: 9371232
[TBL] [Abstract][Full Text] [Related]
11. Cell-specific targeting in the mouse inner ear using nanoparticles conjugated with a neurotrophin-derived peptide ligand: potential tool for drug delivery.
Roy S; Johnston AH; Newman TA; Glueckert R; Dudas J; Bitsche M; Corbacella E; Rieger G; Martini A; Schrott-Fischer A
Int J Pharm; 2010 May; 390(2):214-24. PubMed ID: 20153412
[TBL] [Abstract][Full Text] [Related]
12. Melanoma cells selected for adhesion to laminin peptides have different malignant properties.
Yamamura K; Kibbey MC; Kleinman HK
Cancer Res; 1993 Jan; 53(2):423-8. PubMed ID: 8417834
[TBL] [Abstract][Full Text] [Related]
13. Antiidiotypic antibodies carrying the "internal image" of peptide YIGSR inhibit spontaneous metastasis of Lewis lung carcinoma in mice.
Koliakos KK; Sapountzi Z; Papageorgiou A; Trachana V; Kotsinou S; Koliakos G
In Vivo; 2002; 16(6):511-8. PubMed ID: 12494895
[TBL] [Abstract][Full Text] [Related]
14. Modification of the C16Y peptide on nanoparticles is an effective approach to target endothelial and cancer cells via the integrin receptor.
Hamano N; Negishi Y; Fujisawa A; Manandhar M; Sato H; Katagiri F; Nomizu M; Aramaki Y
Int J Pharm; 2012 May; 428(1-2):114-7. PubMed ID: 22421321
[TBL] [Abstract][Full Text] [Related]
15. Multimeric forms of Tyr-Ile-Gly-Ser-Arg (YIGSR) peptide enhance the inhibition of tumor growth and metastasis.
Nomizu M; Yamamura K; Kleinman HK; Yamada Y
Cancer Res; 1993 Aug; 53(15):3459-61. PubMed ID: 8339246
[TBL] [Abstract][Full Text] [Related]
16. Enhanced electrostatic interaction between chitosan-modified PLGA nanoparticle and tumor.
Yang R; Shim WS; Cui FD; Cheng G; Han X; Jin QR; Kim DD; Chung SJ; Shim CK
Int J Pharm; 2009 Apr; 371(1-2):142-7. PubMed ID: 19118614
[TBL] [Abstract][Full Text] [Related]
17. Bioconjugation of laminin peptide YIGSR with poly(styrene co-maleic acid) increases its antimetastatic effect on lung metastasis of B16-BL6 melanoma cells.
Mu Y; Kamada H; Kaneda Y; Yamamoto Y; Kodaira H; Tsunoda S; Tsutsumi Y; Maeda M; Kawasaki K; Nomizu M; Yamada Y; Mayumi T
Biochem Biophys Res Commun; 1999 Feb; 255(1):75-9. PubMed ID: 10082658
[TBL] [Abstract][Full Text] [Related]
18. Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide.
Chen X; Wang X; Wang Y; Yang L; Hu J; Xiao W; Fu A; Cai L; Li X; Ye X; Liu Y; Wu W; Shao X; Mao Y; Wei Y; Chen L
J Control Release; 2010 Jul; 145(1):17-25. PubMed ID: 20307599
[TBL] [Abstract][Full Text] [Related]
19. Identification of an active site on the laminin alpha5 chain globular domain that binds to CD44 and inhibits malignancy.
Hibino S; Shibuya M; Engbring JA; Mochizuki M; Nomizu M; Kleinman HK
Cancer Res; 2004 Jul; 64(14):4810-6. PubMed ID: 15256450
[TBL] [Abstract][Full Text] [Related]
20. Inhibition by human recombinant tissue inhibitor of metalloproteinases of human amnion invasion and lung colonization by murine B16-F10 melanoma cells.
Schultz RM; Silberman S; Persky B; Bajkowski AS; Carmichael DF
Cancer Res; 1988 Oct; 48(19):5539-45. PubMed ID: 3416307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
